Trial Profile
Clinical Trials Insight: 700023098
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2009
Price :
$35
*
At a glance
- Drugs NE 3107 (Primary)
- Indications Multiple sclerosis; Rheumatoid arthritis; Type 2 diabetes mellitus; Ulcerative colitis
- Focus Adverse reactions
- Sponsors Harbor Therapeutics
- 11 May 2007 New trial record.